Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

被引：1197

作者：

Robertson, A. Gordon ^{[1
]}

Kim, Jaegil ^{[2
]}

Al-Ahmadie, Hikmat ^{[3
]}

Bellmunt, Joaquim ^{[4
,5
]}

Guo, Guangwu ^{[5
,6
]}

Cherniack, Andrew D. ^{[2
]}

Hinoue, Toshinori ^{[7
]}

Laird, Peter W. ^{[7
]}

Hoadley, Katherine A. ^{[8
]}

Akbani, Rehan ^{[9
]}

Castro, Mauro A. A. ^{[10
]}

Gibb, Ewan A. ^{[1
]}

Kanchi, Rupa S. ^{[9
]}

Gordenin, Dmitry A. ^{[11
]}

Shukla, Sachet A. ^{[5
,6
]}

Sanchez-Vega, Francisco ^{[12
]}

Hansel, Donna E. ^{[13
]}

Czerniak, Bogdan A. ^{[14
]}

Reuter, Victor E. ^{[3
]}

Su, Xiaoping ^{[9
]}

Carvalho, Benilton de Sa ^{[15
]}

Chagas, Vinicius S. ^{[10
]}

Mungall, Karen L. ^{[1
]}

Sadeghi, Sara ^{[1
]}

Pedamallu, Chandra Sekhar ^{[2
]}

Lu, Yiling ^{[16
]}

Klimczak, Leszek J. ^{[17
]}

Zhang, Jiexin ^{[9
]}

Choo, Caleb ^{[1
]}

Ojesina, Akinyemi I. ^{[18
]}

Bullman, Susan ^{[2
]}

Leraas, Kristen M. ^{[19
]}

Lichtenberg, Tara M. ^{[19
]}

Wu, Catherine J. ^{[20
]}

Schultz, Nicholaus ^{[12
]}

Getz, Gad ^{[2
]}

Meyerson, Matthew ^{[5
,21
]}

Mills, Gordon B. ^{[16
]}

McConkey, David J. ^{[22
]}

Weinstein, John N. ^{[9
,16
]}

Kwiatkowski, David J. ^{[23
]}

Lerner, Seth P. ^{[24
]}

机构：

[1] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada

[2] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA

[4] Dana Farber Canc Inst, Bladder Canc Ctr, Dept Med, PSMAR IMIM Lab, Boston, MA 02215 USA

[5] Harvard Univ, Boston, MA 02115 USA

[6] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[7] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA

[8] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27514 USA

[9] Univ Texas Houston, MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[10] Univ Fed Parana, Polytech Ctr, Bioinformat & Syst Biol Lab, BR-80060000 Curitiba, Parana, Brazil

[11] NIEHS, NIH, Genome Integr & Struct Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA

[12] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10065 USA

[13] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA

[14] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[15] Univ Estadual Campinas, Dept Stat, Biostat & Computat Biol Lab, BR-13083859 Sao Paulo, Brazil

[16] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[17] NIEHS, NIH, Integrat Bioinformat Support Grp, POB 12233, Res Triangle Pk, NC 27709 USA

[18] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA

[19] Res Inst Nationwide Childrens Hosp, Biospecimen Core Resource, Columbus, OH 43205 USA

[20] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, 75 Francis St, Boston, MA 02115 USA

[21] Dana Farber Canc Inst, Pathol & Med Oncol, Boston, MA 02115 USA

[22] Johns Hopkins Univ, Greenberg Bladder Canc Inst, Baltimore, MD 21218 USA

[23] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

[24] Baylor Coll Med, Dan L Duncan Canc Ctr, Scott Dept Urol, Houston, TX 77030 USA

来源：

CELL | 2017年 / 171卷 / 03期

关键词：

SOMATIC ERCC2 MUTATIONS; PHASE PROTEIN ARRAY; UROTHELIAL CARCINOMA; GENETIC ALTERATIONS; LUMINAL SUBTYPES; EXPRESSION; RECEPTOR; ACCURATE; BASAL; QUANTIFICATION;

D O I：

10.1016/j.cell.2017.09.007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We report a comprehensive analysis of 412 muscleinvasive bladder cancers characterized by multiple TCGA analytical platforms. Fifty-eight genes were significantly mutated, and the overall mutational load was associated with APOBEC-signature mutagenesis. Clustering by mutation signature identified a high-mutation subset with 75% 5-year survival. mRNA expression clustering refined prior clustering analyses and identified a poor-survival "neuronal'' subtype in which the majority of tumors lacked small cell or neuroendocrine histology. Clustering by mRNA, long non-coding RNA ( lncRNA), and miRNA expression converged to identify subsets with differential epithelial-mesenchymal transition status, carcinoma in situ scores, histologic features, and survival. Our analyses identified 5 expression subtypes that may stratify response to different treatments.

引用

页码：540 / +

页数：42

共 50 条

[41] Optimal Management of the Elderly Patient with Muscle-Invasive Bladder Cancer
Eugene J. Pietzak
George W. Drach
S. Bruce Malkowicz
Thomas J. Guzzo
Current Translational Geriatrics and Experimental Gerontology Reports, 2013, 2 (2): : 58 - 65
[42] Fibulin-3 promotes muscle-invasive bladder cancer
Han, A. L.
Veeneman, B. A.
El-Sawy, L.
Day, K. C.
Day, M. L.
Tomlins, S. A.
Keller, E. T.
ONCOGENE, 2017, 36 (37) : 5243 - 5251
[43] Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
Choi, Woonyoung
Czemiak, Bogdan
Ochoa, Andrea
Su, Xiaoping
Siefker-Radtke, Arlene
Dinney, Colin
McConkey, David J.
NATURE REVIEWS UROLOGY, 2014, 11 (07) : 400 - 410
[44] Is trimodal therapy the current standard for muscle-invasive bladder cancer?
Valcarcel, M. Lopez
Los Arcos, M. Barrado
Molina, M. Ferri
Belmonte, I. Cienfuegos
Santana, V. Duque
Borau, P. Gajate
Ibiza, J. Fernandez
Maestro, M. alvarez
Sargos, P.
Campos, F. Lopez
Counago, F.
ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (05): : 345 - 355
[45] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Zargar, Homayoun
Espiritu, Patrick N.
Fairey, Adrian S.
Mertens, Laura S.
Dinney, Colin P.
Mir, Maria C.
Krabbe, Laura-Maria
Cookson, Michael S.
Jacobsen, Niels-Erik
Gandhi, Nilay M.
Griffin, Joshua
Montgomery, Jeffrey S.
Vasdev, Nikhil
Yu, Evan Y.
Youssef, David
Xylinas, Evanguelos
Campain, Nicholas J.
Kassouf, Wassim
Dall'Era, Marc A.
Seah, Jo-An
Ercole, Cesar E.
Horenblas, Simon
Sridhar, Srikala S.
McGrath, John S.
Aning, Jonathan
Shariat, Shahrokh F.
Wright, Jonathan L.
Thorpe, Andrew C.
Morgan, Todd M.
Holzbeierlein, Jeff M.
Bivalacqua, Trinity J.
North, Scott
Barocas, Daniel A.
Lotan, Yair
Garcia, Jorge A.
Stephenson, Andrew J.
Shah, Jay B.
van Rhijn, Bas W.
Daneshmand, Siamak
Spiess, Philippe E.
Black, Peter C.
EUROPEAN UROLOGY, 2015, 67 (02) : 241 - 249
[46] Prognostic value of apoptotic activit in muscle-invasive bladder cancer
Ristic, Ana
Velickovic, Jubinka Jankovic
Stokanovic, Dragana
VOJNOSANITETSKI PREGLED, 2011, 68 (06) : 511 - 514
[47] Optimizing care and outcomes of patients with muscle-invasive bladder cancer
Booth, Christopher M.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (9-10): : E625 - E627
[48] Optimal Management of the Elderly Patient with Muscle-Invasive Bladder Cancer
Pietzak, Eugene J.
Drach, George W.
Malkowicz, S. Bruce
Guzzo, Thomas J.
CURRENT GERIATRICS REPORTS, 2013, 2 (02) : 58 - 65
[49] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
Kaneko, Gou
Kikuchi, Eiji
Matsumoto, Kazuhiro
Obata, Jun
Nakamura, So
Miyajima, Akira
Oya, Mototsugu
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
[50] Recent progress with next-generation biomarkers in muscle-invasive bladder cancer
Contreras-Sanz, Alberto
Roberts, Morgan E.
Seiler, Roland
Black, Peter C.
INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (01) : 7 - 15

← 1 2 3 4 5 →